- Tytuł:
- Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Healthy Longevity March 2024 5(3):e182-e193
Czasopismo naukowe